Welcome to our dedicated page for Proficient Alpha Acquisition news (Ticker: PAAC), a resource for investors and traders seeking the latest updates and insights on Proficient Alpha Acquisition stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Proficient Alpha Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Proficient Alpha Acquisition's position in the market.
Proem Acquisition Corp I (PAAC) priced an initial public offering of 13,000,000 units at $10.00 per unit for gross proceeds of approximately $130,000,000. Each unit contains one ordinary share and one-half of a redeemable warrant.
Units are expected to begin trading on the Nasdaq Global Market as PAACU on February 12, 2026, with ordinary shares and warrants expected to trade as PAAC and PAACW after separation. The offering is expected to close February 13, 2026, led by Clear Street LLC, with a 45-day 15% over-allotment option for up to 1,950,000 additional units. Registration was declared effective by the SEC on February 11, 2026.
